NM-BL

· Nordmark Arzneimittel GmbH & Co. KG

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NM-BL, covering 2016-06-07 to 2016-06-07. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Tolerability of NM-BL in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis [Phase 1, Phase 2]

See pricing